Reflections on Section 5 of the FTC Act & the FTC’s Case Against Intel
Daniel Crane, Feb 28, 2010 The Federal Trade Commission’s (“FTC’s”) unprecedented enforcement action against Intel raises profound issues concerning the scope of the FTC’s powers to give a construction to Section 5 of the FTC Act that goes beyond the substantive reach of the Sherman Act. While I have urged the FTC to assert such […]
DEC-10(2)
In this issue: Our final 2010 issue continues using a crystal ball. Our previous issue asked authors to look at the EU competition policy world of 2025. For this issue, we posed the same challenge to U.S. authors. Some chose very specific topics (tying, reverse payments) while others are broader in scope—but all have the […]
DEC-10(1)
In this issue: To wrap up 2010, under the sponsorship of Editorial Advisory Member James Killick, we decided to do a little crystal ball gazing. We asked seven European authors to look at what will be, needs to be, and might be changed in the EU competition policy world of 2025. Ken Daly writes, “… […]
NOV-10(1)
In this issue: A New York-based think tank, the Conference Board, has said China and India will account for half the world’s economic growth in the next 10 years. Even if this is optimistic, understanding the financial, regulatory, and business climate in these two countries is crucial to any global business. Yet both have nascent […]
OCT-10(2)
In this issue: In August, the FTC and DOJ issued their new horizontal merger guidelines. In this special double issue, we explore if these new guidelines accomplish the Agencies’ stated goals: describing their go-to analytical techniques; increasing transparency of the review process; and developing a framework to assist the courts in interpreting the antitrust laws. […]
OCT-10(1)
In this issue: Healthcare is not only a contentious antitrust issue, but a highly confusing one; we focus here on clinical integration. Christi Braun looks at the challenge of promoting cost-effective health care while controlling joint contracting; Heather Cooper gives some cautionary advice to physicians looking to join forces; Ashley Fischer & David Marx, Jr. […]
SEP-10(2)
In this issue: This issue contains a special bonus, but first we take a look at two recent EU court decisions. Kent Bernard, Sean-Paul Brankin, and Kristina Nordlander & Patrick Harrison analyze the (at long last!) judgment on AstraZeneca, raising real concerns about the future of legal protection for IP and R&D. Angela Laghezza contributes […]
SEP-10(1)
In this issue: This issue, organized by guest editor Paul Lugard, takes an indepth look at the pending revision of the EU competition rules on horizontal cooperation agreements. Paul leads off with a summary of the issues and an introduction to the articles, then Julia Holtz & Tero Louko weigh in on standard setting; Anne […]
AUG-10(2)
In this issue: This issue, organized by guest editor Mark Katz, is dedicated to developments in Canadian competition law and policy. It is a little known fact that Canada enacted its first competition legislation one year before the U.S. Sherman Act became law. But it is certainly widely recognized that Canada is now one of […]
AUG-10(1)
In this issue: Courts and authorities—both in the United States and Europe—have muddied the waters regarding various class issues. To try to clear things up a bit, we first asked two groups of authors—Donald Falk, Archis Parasharami, & Marcia Goodman and Jay Himes & William Reiss—to look at the 9th Circuit’s Dukes decision, which conflicts […]
JULY-10(2)
In this issue: This issue, organized by guest editor Glen Weyl, concerns one of the hottest topics in antitrust and economics—two-sided markets. Understanding the distinction between conventional and two-sided markets is a necessary challenge for practitioners, corporate executives, and regulators alike; our writers investigate some of these differences. Lapo Filistrucchi questions how many markets are, […]
Featured News
EU Closes Antitrust Case Against Edwards Lifesciences After Policy Withdrawal
Feb 16, 2026 by
CPI
Federal Judge Rules AI Chatbot Conversations Can Be Seized as Evidence in Fraud Cases
Feb 16, 2026 by
CPI
Michigan Alleges Oil Industry Conspired to Stall EVs and Renewable Power
Feb 16, 2026 by
CPI
Jones Day Expands German Antitrust Practice with Senior Munich Hire
Feb 16, 2026 by
CPI
UK Considers Australian-Style Social Media Ban for Under-16s; Moves to Tighten AI Safety Laws
Feb 16, 2026 by
CPI
Antitrust Mix
Antitrust Chronicle® – Hub-&-Spoke Conspiracies
Jan 26, 2026 by
CPI
A Data Analytics Company as the Hub in a Hub-and-Spoke Cartel
Jan 26, 2026 by
Joseph Harrington
Hub and Spoke Cartels
Jan 26, 2026 by
Patrick Van Cayseele
Hub-and-Spoke Collusion or Vertical Exclusion? Identifying the Rim in Hub-and-Spoke Conspiracies
Jan 26, 2026 by
Rosa Abrantes-Metz, Pedro Gonzaga, Laura Ildefonso & Albert Metz
The Algorithmic Middleman in a Hub-and-Spoke Conspiracy: Divergent Court Decisions and the Expanding Patchwork of State and Local Regulations
Jan 26, 2026 by
Bradley C. Weber